Eurofins Executive and Leadership Team

Alexandra Kim, the Chief Financial Officer, Business Line at Eurofins, manages the financial strategy and performance for specific business units within the life sciences network. Kim oversees budgeting, forecasting, and financial reporting, ensuring fiscal discipline across diverse analytical testing services. This position is critical for supporting Eurofins' global leadership in areas like food, environmental, and pharmaceutical product testing. Alexandra Kim's financial acumen guides investment decisions in agroscience contract research and BioPharma contract development and manufacturing. The Chief Financial Officer, Business Line's responsibilities include optimizing financial operations to enhance profitability and support strategic growth initiatives, particularly in the expanding fields of genomics and clinical diagnostics. Kim's financial oversight is essential for maintaining Eurofins' market position and driving sustainable revenue.

Jatin Vij, the Chief Financial Officer, Business Lines (Multiple, Asia) at Eurofins, directs financial operations and strategy for a portfolio of business lines across the Asian region. Vij is responsible for financial planning, analysis, and resource allocation, ensuring robust fiscal management for Eurofins' extensive testing services in Asia. This role is key to supporting the company's market leadership in food, environmental, and pharmaceutical testing within this critical geographic area. Jatin Vij's financial leadership facilitates expansion in agroscience contract research and supports BioPharma contract development and manufacturing operations across multiple Asian markets. The Chief Financial Officer, Business Lines (Multiple, Asia)'s focus includes driving financial performance, managing risk, and identifying growth opportunities to strengthen Eurofins' presence in genomics and clinical diagnostic testing throughout Asia. Vij's expertise is vital for regional financial success.

Michael Mmuscatiello, the Chief Operating Officer at Eurofins, directs the operational execution across the global network of life sciences companies. Overseeing the day-to-day functions, Mmuscatiello ensures the seamless delivery of comprehensive analytical testing services that Eurofins provides to clients in the food, environmental, pharmaceutical, and cosmetic sectors. This leadership role involves optimizing internal processes to maintain Eurofins' position as a world leader in discovery pharmacology, forensics, and advanced material sciences. By driving efficiency, Michael Mmuscatiello supports the company's expansion in agroscience contract research services and its growing presence in BioPharma contract development and manufacturing. The Chief Operating Officer's focus remains on scaling operations to meet increasing global demand for Eurofins' specialized testing capabilities, particularly in esoteric and molecular clinical diagnostic testing.

Lenore Coyle, the President, Eurofins CRL Cosmetics, Inc. at Eurofins, leads the specialized cosmetic testing division, driving its strategic growth and operational excellence. Coyle oversees the comprehensive range of analytical services tailored for the cosmetics industry, ensuring compliance with global regulatory standards and client expectations. This leadership role is critical for maintaining Eurofins' prominent position in cosmetic product testing and safety assessments. Lenore Coyle focuses on expanding service offerings and enhancing laboratory capabilities to meet evolving market demands for innovative cosmetic formulations and ingredients. The President, Eurofins CRL Cosmetics, Inc.'s responsibilities include fostering strong client relationships and driving business development within the cosmetics sector. Coyle's strategic direction ensures the continued success and market leadership of Eurofins CRL Cosmetics.

Camila Gadotti, the President at Eurofins, directs key business operations and strategic initiatives within the organization's extensive life sciences network. Gadotti oversees the delivery of a broad spectrum of analytical testing services, reinforcing Eurofins' global leadership in sectors such as food, environmental, and pharmaceutical product testing. This executive role involves guiding the expansion of services in discovery pharmacology, forensics, and advanced material sciences. Camila Gadotti's leadership supports the growth of agroscience contract research services and strengthens Eurofins' capabilities in BioPharma contract development and manufacturing. The President's focus includes advancing the company's emerging position in esoteric and molecular clinical diagnostic testing, ensuring operational efficiency and market responsiveness across diverse business lines. Gadotti's strategic vision drives Eurofins' continued success.

Mary Krogull, the President at Eurofins, spearheads strategic development and operational oversight for significant segments of the company's global life sciences operations. Krogull ensures the effective deployment of Eurofins' comprehensive analytical testing services, reinforcing its standing as a world leader in food, environmental, and pharmaceutical product analysis. This executive position guides the advancement of services in areas including discovery pharmacology, forensics, and advanced material sciences. Mary Krogull's leadership is crucial for expanding agroscience contract research services and enhancing BioPharma contract development and manufacturing capabilities. The President's strategic priorities include solidifying Eurofins' growing influence in esoteric and molecular clinical diagnostic testing, driving innovation and operational excellence across its diverse service portfolio. Krogull's direction propels Eurofins forward.

Jp Boutrand, the President at Eurofins, manages critical business units and drives strategic growth across the company's global life sciences network. Boutrand oversees the execution of Eurofins' comprehensive analytical testing services, reinforcing its market leadership in food, environmental, and pharmaceutical product testing. This executive role is pivotal in advancing services within discovery pharmacology, forensics, and advanced material sciences. Jp Boutrand's leadership supports the expansion of agroscience contract research services and enhances BioPharma contract development and manufacturing operations. The President's strategic focus includes strengthening Eurofins' significant presence in esoteric and molecular clinical diagnostic testing, ensuring high-quality service delivery and operational efficiency. Boutrand's strategic initiatives are key to Eurofins' continued market expansion.

Marisa Feller, the President at Eurofins, directs strategic initiatives and operational performance for key business segments within the global life sciences organization. Feller ensures the effective delivery of Eurofins' extensive analytical testing services, solidifying its position as a leader in food, environmental, and pharmaceutical product testing. This executive role guides the development and expansion of services in discovery pharmacology, forensics, and advanced material sciences. Marisa Feller's leadership is vital for growing agroscience contract research services and enhancing BioPharma contract development and manufacturing. The President's strategic focus includes advancing Eurofins' emerging capabilities in esoteric and molecular clinical diagnostic testing, driving innovation and operational excellence across its diverse service offerings. Feller's strategic oversight is critical for sustained growth.

Scott Fyfe, the Chief Technology Officer at Eurofins, architects the technological infrastructure supporting the organization's extensive analytical testing services. Fyfe drives innovation in digital solutions and data management, crucial for Eurofins' leadership in genomics and clinical studies support. This role involves enhancing the technological capabilities that underpin Eurofins' services in food, environmental, pharmaceutical, and cosmetic product testing, as well as advanced material sciences. By implementing cutting-edge technologies, Scott Fyfe ensures the integrity and efficiency of discovery pharmacology and forensics testing. The Chief Technology Officer's strategic vision extends to bolstering Eurofins' emerging position in esoteric and molecular clinical diagnostic testing, ensuring robust and scalable platforms. Fyfe's leadership is pivotal in maintaining Eurofins' competitive edge through technological advancement across all its business lines.

Jamie Bendrick-Peart, the Chief Operations Officer at Eurofins, oversees the strategic direction and execution of operational activities across the company's global life sciences network. Bendrick-Peart is instrumental in enhancing the efficiency and scalability of Eurofins' comprehensive analytical testing services, supporting its world-leading position in food, environmental, and pharmaceutical product testing. This leadership position involves optimizing laboratory operations and supply chain management to ensure consistent quality and timely delivery of results. Jamie Bendrick-Peart drives operational excellence in discovery pharmacology, forensics, and advanced material sciences, while also supporting the growth of agroscience contract research services. The Chief Operations Officer's mandate includes refining processes for BioPharma contract development and manufacturing and strengthening Eurofins' capabilities in esoteric and molecular clinical diagnostic testing, ensuring operational readiness for future market demands.